Načítá se...
Eltrombopag, a thrombopoietin receptor agonist, enhances human umbilical cord blood hematopoietic stem/primitive progenitor cell expansion and promotes multi-lineage hematopoiesis
Umbilical cord blood (UCB) transplantation has emerged as promising therapy, but is challenged by scarcity of stem cells. Eltrombopag is a non-peptide, thrombopoietin (TPO) receptor agonist, which selectively activates c-Mpl in humans and chimpanzees. We investigated eltrombopag’s effects on human U...
Uloženo v:
Hlavní autoři: | , , , , |
---|---|
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
2012
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3412938/ https://ncbi.nlm.nih.gov/pubmed/22683680 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.scr.2012.05.001 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|